Author

Milan Radovich

Indiana University IndianapolisORCID 0000-0001-9667-156XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Alejandro Recio‐BoilesiD· 1 shared Alex Patrick FarrelliD· 1 shared Alexander GawronskiiD· 1 shared Amber N. ClementsiD· 1 shared Andrea L. CasillasiD· 1 shared Andrew McPhersoniD· 1 shared Anne E. CressiD· 1 shared Bryan Paul SchneideriD· 1 shared

Activity by Year

2017-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandro Recio‐BoilesORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer Immunology ResearchPeer-reviewedFeb 21, 2025

Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome 1 activation and sensitizes prostate cancer to immunotherapy

Amber N. Clements, Andrea L. Casillas, Caitlyn E. Flores…·Noel A. Warfel

This study shows that inhibiting PIM kinases in tumor-associated macrophages reduces inflammasome activation and improves response to immunotherapy in prostate cancer.

13 citationstop 4%

mousebulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineJCO Precision OncologyPeer-reviewedFeb 24, 2022

CLINICAL OPPORTUNITIES FOR GERMLINE PHARMACOGENETICS AND MANAGEMENT OF DRUG-DRUG INTERACTIONS IN PATIENTS WITH ADVANCED SOLID CANCERS

Tyler Shugg, Reynold C. Ly, Elizabeth J. Rowe…·Todd C. Skaar

The paper assesses opportunities for germline pharmacogenetics and drug-drug interaction management in advanced cancer patients using EHR data and CPIC guidelines.

19 citations

humanelectronic health records

𝕏 PostBluesky

BioinformaticsBioinformaticsPeer-reviewedDec 15, 2017

Computational proteogenomic identification and functional interpretation of translated fusions and micro structural variations in cancer

Yen-Yi Lin, Alexander Gawronski, Faraz Hach…·S. Cenk Şahinalp

The paper introduces a computational framework integrating genomic, transcriptomic, and proteomic data to identify and interpret translated fusions and micro structural variations in cancer, finding many novel peptides and private aberrations in breast cancer.

11 citations

humanwhole-genome sequencing

𝕏 PostBluesky